AnalystsThomas ShraderThomas Shrader's Stock Forecasts
AnalystsThomas Shrader
Analyst Ranking
Bottom 2%
#5455 out of 5549 analysts
Average Return
-11.41%
Win Rate
27%37 out of 139
Risk vs Reward
Poor
Good
Thomas Shrader's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ovid Therapeutics IncOVID | +474.32% | $0.44 | $2.55 | 2025-03-24 - 2026-03-23 | Strong Buy |
Annexon IncANNX | +136.19% | $2.10 | $4.96 | 2023-05-25 - 2024-05-24 | Strong Buy |
Inmune Bio IncINMB | +117.73% | $10.38 | $22.60 | 2020-09-01 - 2021-08-30 | Strong Buy |
Biohaven LtdBHVN | +101.08% | $16.74 | $33.66 | 2022-12-02 - 2023-12-01 | Strong Buy |
Biohaven LtdBHVN | +93.32% | $8.53 | $16.49 | 2025-11-06 - 2026-10-29 | Strong Buy |
Thomas Shrader Analyst Color
Get additional color on Thomas Shrader's coverage of popular stocks
Thomas Shrader's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Serina Therapeutics IncSER | 3 | Strong Buy | $8.00 | +323.28% | Reiterates | 5 days ago |
Harrow IncHROW | 9 | Strong Buy | $63.00 | +110.07% | Reiterates | 24 days ago |
Vaxcyte IncPCVX | 9 | Strong Buy | $89.00 | +42.15% | Reiterates | 25 days ago |
Aldeyra Therapeutics IncALDX | 3 | Strong Buy | $9.00 | +1,265.71% | Reiterates | a month ago |
Arcturus Therapeutics Holdings IncARCT | 3 | Strong Buy | $20.00 | +64.61% | Maintains | a month ago |
Ac Immune SaACIU | 8 | Strong Buy | $8.00 | +237.55% | Reiterates | a month ago |
Tiziana Life Sciences LtdTLSA | 2 | Strong Buy | $7.00 | +673.48% | Reiterates | a month ago |
Acumen Pharmaceuticals IncABOS | 6 | Strong Buy | $8.00 | +249.34% | Reiterates | a month ago |
Coya Therapeutics IncCOYA | 4 | Strong Buy | $16.00 | +302.01% | Reiterates | a month ago |
Nrx Pharmaceuticals IncNRXP | 7 | Strong Buy | $10.00 | +275.94% | Reiterates | 2 months ago |
Invivyd IncIVVD | 8 | Strong Buy | $10.00 | +1,561.13% | Reiterates | 2 months ago |
Opus Genetics IncIRD | 6 | Strong Buy | $12.00 | +228.77% | Reiterates | 2 months ago |
Bioage Labs IncBIOA | 4 | Strong Buy | $40.00 | +573.40% | Reiterates | 2 months ago |
Neonc Technologies Holdings IncNTHI | 3 | Strong Buy | $15.00 | +380.77% | Reiterates | 2 months ago |
Bright Minds Biosciences IncDRUG | 6 | Strong Buy | $147.00 | N/A | Reiterates | 2 months ago |
Alto Neuroscience IncANRO | 3 | Strong Buy | $37.00 | +57.65% | Maintains | 3 months ago |
Gain Therapeutics IncGANX | 7 | Strong Buy | $5.00 | +320.17% | Reiterates | 3 months ago |
Compass Pathways PLCCMPS | 4 | Strong Buy | $25.00 | +105.09% | Maintains | 4 months ago |
Novavax IncNVAX | 2 | Strong Buy | $19.00 | +81.47% | Reiterates | 5 months ago |
Denali Therapeutics IncDNLI | 6 | Strong Buy | $39.00 | +101.86% | Reiterates | 6 months ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $39.00 | +48.01% | Reiterates | 6 months ago |
Ovid Therapeutics IncOVID | 4 | Strong Buy | $4.00 | +56.25% | Reiterates | 7 months ago |
Alector IncALEC | 5 | Strong Buy | $6.00 | +167.86% | Upgrades | 8 months ago |
Biohaven LtdBHVN | 4 | Strong Buy | $16.00 | -2.97% | Reiterates | a year ago |
Verona Pharma PLCVRNA | 4 | Hold | N/A | N/A | Downgrades | a year ago |
Inmune Bio IncINMB | 3 | Hold | N/A | N/A | Downgrades | a year ago |
Promis Neurosciences IncPMN | 1 | Strong Buy | $200.00 | N/A | Initiates Coverage On | 3 years ago |
Precision Biosciences IncDTIL | 1 | Strong Buy | $60.00 | N/A | Maintains | 3 years ago |
Sigilon Therapeutics IncSGTX | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Annexon IncANNX | 2 | Strong Buy | $7.00 | N/A | Maintains | 3 years ago |
Leonabio IncLONA | 2 | Strong Buy | $100.00 | N/A | Maintains | 4 years ago |
Bioatla IncBCAB | 3 | Strong Buy | $650.00 | N/A | Maintains | 4 years ago |
Sqz Biotechnologies CoSQZB | 2 | Strong Buy | $15.00 | N/A | Maintains | 4 years ago |
Pliant Therapeutics IncPLRX | 1 | Strong Buy | $51.00 | N/A | Initiates Coverage On | 6 years ago |
Celularity IncCELU | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 6 years ago |
Oncosec Medical IncONCSQ | 1 | Strong Buy | $220.00 | N/A | Initiates Coverage On | 6 years ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $16.00 | N/A | Initiates Coverage On | 6 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Vaccinex IncVCNX | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
89bio IncETNB | 1 | Strong Buy | $58.00 | N/A | Maintains | 6 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | 6 years ago |
Geron CorpGERN | 1 | Strong Buy | $3.00 | N/A | Maintains | 7 years ago |
Acorda Therapeutics IncACORQ | 1 | Hold | $840.00 | N/A | Maintains | 7 years ago |
Biogen IncBIIB | 3 | Hold | $346.00 | N/A | Downgrades | 8 years ago |
Momenta Pharmaceuticals IncMNTA | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Windtree Therapeutics IncWINT | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Kite Pharma IncKITE | 1 | Hold | N/A | N/A | Downgrades | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.